Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor
- PMID: 234499
Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor
Abstract
Present methods for assay of platelet aggregating agents use freshly prepared platelets. Much time is spent in daily preparation of platelets and standardization presents problems. The preparation of fixed washed platelets (FWP) and their use in two bioassays are described in this report. Washed human platelets were fixed for 48 hours with 4 per cent paraformaldehyde, washed twice in phosphate buffer, pH 6.4, and stored at 4 degrees C. Aggregation of FWP was studied with a macroscopic test and a light absorbance measurement. FWP did not aggregate with adenosine diphosphate, collagen, adrenalin, and thrombin. FWP aggregated with bovine or porcine plasma, poly-L-lysine, and ristocetin with normal human plasma but not with von Willebrand's disease plasma. These observations confirm the direct aggregating effect of these agents. Macroscopic aggregation times were dependent on the amount of aggregating agent (bovine plasma, normal human plasma). A quantitative assay for bovine platelet aggregating factor (PAF) and von Willebrand factor (vWF) with FWP was developed. The ability of FWP to aggregate remained unchanged after 1 month of storage at 4 degrees C. Ristocetin alone caused a decrease in light transmission of FWP suspensions, depending upon the concentration of ristocetin, but did not cause aggregation. FWP constitute a stable reagent suitable for quantitative measurement of PAF and vWF.
Similar articles
-
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465. J Clin Invest. 1973. PMID: 4542944 Free PMC article.
-
Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.Thromb Haemost. 1984 Dec 29;52(3):267-70. Thromb Haemost. 1984. PMID: 6241752
-
Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.Thromb Haemost. 1988 Jun 16;59(3):485-90. Thromb Haemost. 1988. PMID: 3142084
-
[Participation of von Willebrand factor in blood platelet functions].Nihon Rinsho. 1978 Dec 10;36(12):3824-9. Nihon Rinsho. 1978. PMID: 372620 Review. Japanese. No abstract available.
-
[Platelet aggregation caused by ristocetin--its implication and action mechanism].Nihon Rinsho. 1978 Dec 10;36(12):3848-56. Nihon Rinsho. 1978. PMID: 372624 Review. Japanese. No abstract available.
Cited by
-
The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.J Clin Invest. 1978 May;61(5):1168-75. doi: 10.1172/JCI109032. J Clin Invest. 1978. PMID: 307006 Free PMC article.
-
Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.J Clin Invest. 1977 Oct;60(4):914-21. doi: 10.1172/JCI108846. J Clin Invest. 1977. PMID: 70434 Free PMC article.
-
Immunoinhibition of ristocetin-induced platelet aggregation.J Clin Invest. 1977 Jan;59(1):143-8. doi: 10.1172/JCI108612. J Clin Invest. 1977. PMID: 299747 Free PMC article.
-
von Willebrand protein facilitates platelet incorporation in polymerizing fibrin.J Clin Invest. 1986 Oct;78(4):1112-9. doi: 10.1172/JCI112668. J Clin Invest. 1986. PMID: 3489737 Free PMC article.
-
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.J Clin Invest. 1981 Aug;68(2):321-8. doi: 10.1172/jci110259. J Clin Invest. 1981. PMID: 6790574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous